aH5N8c on Day 202: Clinical Trials

1 trial of aH5N8c on Day 202, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow aH5N8c on Day 202: new trials by email Literature Review of aH5N8c on Day 202 trials Research Report on aH5N8c on Day 202

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on Day 22 - Influenza, Human, Infections
Phase 2CompletedSeqirus4802023-06-072024-12-13

Conditions studied

Infections (1)  ·  Influenza, Human (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Sponsors

Seqirus (1)

Countries

United States (1)